Not Tagged
Not Tagged
['solid tumor']
the phase 1 start-001 study (nct05592626) is evaluating star0602, a tcr-targeting bifunctional antibody, in patients with solid tumors refractory to checkpoint inhibitors. #asco23 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.